• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylbutylamines

Research Brief on Benzeneethanol, α-(2-aminoethyl)-α-methyl- (CAS: 63574-07-2) in Chemical Biology and Pharmaceutical Applications

Benzeneethanol, α-(2-aminoethyl)-α-methyl- (CAS: 63574-07-2) is a chemical compound of significant interest in the fields of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been the subject of recent studies due to its potential applications in drug development and biochemical modulation. The presence of both amino and hydroxyl functional groups in its structure makes it a versatile intermediate for synthesizing more complex molecules with potential therapeutic effects.

Recent studies have focused on the synthesis and characterization of Benzeneethanol, α-(2-aminoethyl)-α-methyl-, particularly its role as a precursor in the development of novel pharmacologically active compounds. Research published in the Journal of Medicinal Chemistry (2023) highlights its utility in the synthesis of beta-adrenergic receptor agonists, which are critical in treating conditions such as asthma and cardiovascular diseases. The compound's ability to act as a chiral building block has also been explored, offering pathways to enantioselective synthesis of targeted drug molecules.

In addition to its synthetic applications, Benzeneethanol, α-(2-aminoethyl)-α-methyl- has been investigated for its biochemical properties. A 2024 study in Bioorganic & Medicinal Chemistry Letters demonstrated its interaction with specific enzyme targets, particularly those involved in neurotransmitter regulation. This interaction suggests potential applications in neurological disorders, although further in vivo studies are required to validate these findings. The compound's moderate solubility and stability under physiological conditions make it a promising candidate for further pharmacological evaluation.

One of the key challenges in utilizing Benzeneethanol, α-(2-aminoethyl)-α-methyl- lies in optimizing its bioavailability and minimizing potential side effects. Recent advancements in prodrug strategies, as discussed in a 2023 review in Advanced Drug Delivery Reviews, have proposed chemical modifications to enhance its delivery and efficacy. These modifications include esterification and conjugation with biocompatible polymers, which could improve its therapeutic index.

Looking ahead, the integration of computational chemistry and high-throughput screening methods is expected to accelerate the exploration of Benzeneethanol, α-(2-aminoethyl)-α-methyl- derivatives. Molecular docking studies, as reported in a 2024 preprint on ChemRxiv, have identified potential binding affinities with various protein targets, opening new avenues for drug discovery. Collaborative efforts between academic and industrial researchers are likely to drive the translation of these findings into clinical applications in the coming years.

In conclusion, Benzeneethanol, α-(2-aminoethyl)-α-methyl- (CAS: 63574-07-2) represents a compound of growing importance in pharmaceutical research. Its dual functionality and structural flexibility make it a valuable tool for drug development, particularly in the realms of neurology and cardiovascular therapeutics. Continued research into its pharmacokinetics and toxicological profile will be essential to fully realize its potential in clinical settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)